Company Information

POLY MEDICURE LTD.

NSE : POLYMEDBSE : 531768ISIN CODE : INE205C01021Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE1588.804.6 (+0.29 %)
PREV CLOSE ( ) 1584.20
OPEN PRICE ( ) 1580.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 441
TODAY'S LOW / HIGH ( )1576.85 1595.95
52 WK LOW / HIGH ( )921 1727
NSE1589.204.55 (+0.29 %)
PREV CLOSE( ) 1584.65
OPEN PRICE ( ) 1584.65
BID PRICE (QTY) 1589.20 (93)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 24819
TODAY'S LOW / HIGH( ) 1573.10 1595.00
52 WK LOW / HIGH ( )921.1 1729
ChairmanDevendra Mehta
Managing DirectorHimanshu Baid
Company SecretaryAvinash Chandra
Non Executive DirectorJugal Kishore Baid
Mukulika Baid
Joint Managing DirectorRishi Baid
Non Executive Independent DirectorPrakash Chand Surana
Shailendra Raj Mehta
Sandeep Bhargava
Amit Khosla
Sonal Mattoo
Ambrish Mithal
Non Independent & Non Executive DirectorAlessandro Balboni
Incorporation Year : 30-03 1995

Registered Office :

Address : 232- B, 3rd Floor,Okhla Industrial Estate,Phase I I I New Delhi,
Delhi-110020 .

Phone : 011 - 33550700 / 47317000

Email :  info@polymedicure.com 

Industry : Medical Equipment/Supplies/Accessories

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.